ABL Bio (Korea) Buy Hold or Sell Recommendation
| 298380 Stock | KRW 21,500 550.00 2.49% |
Assuming the 90 days trading horizon and your typical level of risk aversion, our recommendation regarding ABL Bio is 'Strong Sell'. Macroaxis provides ABL Bio buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ABL Bio positions. The advice algorithm takes into account all of ABL Bio's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting ABL Bio's buy or sell advice are summarized below:
Real Value 19.1 K | Hype Value 21.5 K | Market Value 21.5 K | Naive Value 22.7 K |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell ABL Bio given historical horizon and risk tolerance towards ABL Bio. When Macroaxis issues a 'buy' or 'sell' recommendation for ABL Bio, the advice is generated through an automated system that utilizes algorithms and statistical models.
ABL |
Execute ABL Bio Buy or Sell Advice
The ABL recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on ABL Bio. Macroaxis does not own or have any residual interests in ABL Bio or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute ABL Bio's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
ABL Bio Trading Alerts and Improvement Suggestions
| ABL Bio had very high historical volatility over the last 90 days | |
| The company reported the revenue of 5.33 B. Net Loss for the year was (43.56 B) with profit before overhead, payroll, taxes, and interest of 8.06 B. | |
| ABL Bio has accumulated about 21.59 B in cash with (40.61 B) of positive cash flow from operations. | |
| Roughly 32.0% of the company shares are owned by insiders or employees |
ABL Bio Returns Distribution Density
The distribution of ABL Bio's historical returns is an attempt to chart the uncertainty of ABL Bio's future price movements. The chart of the probability distribution of ABL Bio daily returns describes the distribution of returns around its average expected value. We use ABL Bio price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of ABL Bio returns is essential to provide solid investment advice for ABL Bio.
| Mean Return | -0.11 | Value At Risk | -4.88 | Potential Upside | 5.88 | Standard Deviation | 3.52 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of ABL Bio historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
ABL Bio Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to ABL Bio or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that ABL Bio's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a ABL stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.11 | |
β | Beta against NYSE Composite | -0.2 | |
σ | Overall volatility | 3.60 | |
Ir | Information ratio | -0.05 |
ABL Bio Volatility Alert
ABL Bio exhibits very low volatility with skewness of 1.08 and kurtosis of 3.17. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure ABL Bio's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact ABL Bio's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.ABL Bio Fundamentals Vs Peers
Comparing ABL Bio's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze ABL Bio's direct or indirect competition across all of the common fundamentals between ABL Bio and the related equities. This way, we can detect undervalued stocks with similar characteristics as ABL Bio or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of ABL Bio's fundamental indicators could also be used in its relative valuation, which is a method of valuing ABL Bio by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare ABL Bio to competition |
| Fundamentals | ABL Bio | Peer Average |
| Return On Equity | 5.6 | -0.31 |
| Return On Asset | -0.31 | -0.14 |
| Operating Margin | (6.16) % | (5.51) % |
| Current Valuation | 866.33 B | 16.62 B |
| Shares Outstanding | 45.3 M | 571.82 M |
| Shares Owned By Insiders | 31.53 % | 10.09 % |
| Shares Owned By Institutions | 12.89 % | 39.21 % |
| Price To Sales | 101.38 X | 11.42 X |
| Revenue | 5.33 B | 9.43 B |
| Gross Profit | 8.06 B | 27.38 B |
| EBITDA | (53.58 B) | 3.9 B |
| Net Income | (43.56 B) | 570.98 M |
| Cash And Equivalents | 21.59 B | 2.7 B |
| Total Debt | 72.32 M | 5.32 B |
| Debt To Equity | 1.40 % | 48.70 % |
| Current Ratio | 14.71 X | 2.16 X |
| Cash Flow From Operations | (40.61 B) | 971.22 M |
| Number Of Employees | 7 | 18.84 K |
| Beta | 1.08 | -0.15 |
| Market Capitalization | 958.17 B | 19.03 B |
| Total Asset | 65.45 B | 29.47 B |
| Net Asset | 65.45 B |
ABL Bio Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as ABL . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.0402 | |||
| Daily Balance Of Power | (0.61) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 21950.0 | |||
| Day Typical Price | 21800.0 | |||
| Market Facilitation Index | 900.0 | |||
| Price Action Indicator | (725.00) | |||
| Period Momentum Indicator | (550.00) |
About ABL Bio Buy or Sell Advice
When is the right time to buy or sell ABL Bio? Buying financial instruments such as ABL Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having ABL Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Munis Funds Thematic Idea Now
Munis Funds
Funds or Etfs that invest in fixed income securities issued by states, cities, and towns as well as other public entities. The Munis Funds theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Munis Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out ABL Bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the ABL Bio information on this page should be used as a complementary analysis to other ABL Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for ABL Stock analysis
When running ABL Bio's price analysis, check to measure ABL Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABL Bio is operating at the current time. Most of ABL Bio's value examination focuses on studying past and present price action to predict the probability of ABL Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABL Bio's price. Additionally, you may evaluate how the addition of ABL Bio to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |